PRISM MediaWire

TV and Streaming

Seaport Global Advocates a Buy, Elevates Rating for fuboTV (FUBO)

News York, March 04, 2024 - PRISM MediaWire - On Monday, Seaport Global Securities revised its rating on fuboTV (NYSE: FUBO) (FUBO) shares, upgrading from Neutral to Buy, and introduced a new price target of $2.50. This adjustment followed a notable 17% surge in the comp...

4 March 2024

AB INTL Reports Forecast Revenues from Its Participated Chinese Market Film Sales

NEW YORK, March 4, 2024 - AB International Group Corp. (OTC: ABQQ) (“AB” or the “Company”), an intellectual property (IP) and movie investment and licensing firm, is pleased to announce update information that based on the information currently available to the Managemen...

4 March 2024

NeuroBo Pharmaceuticals to Commence Clinical Trial Addressing Obesity

New York, March 04, 2024 - PRISM MediaWire - NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO) has obtained Institutional Review Board (IRB) approval to advance its Phase 1 clinical trial of DA-1726, targeting obesity treatment. Anticipated commencement of patient randomizati...

4 March 2024

Auto Parts 4 Less Group Inc. Announces the Reactivation of LiftKits4Less.com to Accelerate Revenue Growth and Diversify Offerings

Las Vegas, NV, March 04, 2024 – PRISM MediaWire - Auto Parts 4 Less Group Inc. (OTC: FLES) (the “Company,” “AutoParts4Less,” “FLES”), a leading online marketplace for automotive parts only, is excited to announce the reactivation of its specialized e-commerce website Lif...

4 March 2024

FREEDOM HOLDINGS CORPORATE UPDATE: MANAGEMENT ANNOUNCES GLENDALE SECURITIES, INC. RECEIVED NOTIFICATION THAT THE FINRA REVIEW OF THE FORM 211 APPLICATION HAS BEEN COMPLETED

Chatsworth, CA, March 04, 2024 - PRISM MediaWire - Freedom Holdings, Inc. aka Freedom Acquisition Corp (OTC: FHLD) ("FHLD" or the "Company") is pleased to announce that Glendale Securities, Inc., received notice from FINRA that they have completed the Form 211 review.

4 March 2024

Lexaria to Progress CBD Hypertension Candidate Following IND Approval

New York, March 01, 2024 - PRISM MediaWire - Lexaria Bioscience (Nasdaq: LEXX) has made significant strides in advancing its CBD-based candidate for hypertension, marked by the recent clearance of its investigational new drug (IND) application by the FDA. With this regul...

1 March 2024

Electric Vehicles

Exploring AI Integration in Electric Vehicles: Indie Semiconductor (INDI) Forges Ahead, Achieves Electrifying Earnings, Establishes Strategic AI Partnership

New York, N.Y., February 29, 2024 - PRISM MediaWire - Indie Semiconductor, Inc. (INDI), renowned for its automotive software solutions and semiconductor expertise, has significantly propelled the advancement of vehicle electrification. In its recent report on Q4 earnings...

1 March 2024

Medical Devices

Establishment Labs Holdings (ESTA) Nearly Doubles Share Price Following Debut on PRISM Women’s Health Index Two Months Ago

New York, N.Y., February 29, 2024 - PRISM MediaWire - Establishment Labs Holdings Inc. (ESTA) surged by 24% today, continuing its upward trajectory that began at the onset of the year. Included in the PRISM Women’s Health Index since its inauguration on January 4th, the ...

29 February 2024

Artificial Intelligence:

"LivePerson, Inc. Shares Plummet 42% Following Q4 Loss and Missed Estimates

New York, N.Y., February 29, 2024 - PRISM MediaWire - LivePerson, Inc. (NASDAQ: LPSN) is currently experiencing significant challenges, evident in its impact on the PRISM NextGen Tech & AI Index where it stands as the largest detractor, causing a notable decline of a...

29 February 2024

Enveric Biosciences Makes Strides in Mental Health Treatment, Witnesses 127% Surge in Shares through Out-Licensing of Compound Classes

New York, N.Y., February 29, 2024 - PRISM MediaWire - Enveric Biosciences (NASDAQ: ENVB), a biotechnology firm specializing in the development of neuroplastogenic small-molecule therapeutics for mental health disorders, has announced the initiation of negotiations via th...

29 February 2024